查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1997179

腦脊髓液引流導管市場：按產品類型、材料、應用、最終用途和分銷管道分類的全球市場預測，2026-2032年

Cerebrospinal Fluid Drainage Catheter Market by Product Type, Material, Application, End Use, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，腦脊髓液引流導管市場價值將達到 3.1233 億美元，到 2026 年將成長至 3.4265 億美元，到 2032 年將達到 5.6743 億美元，年複合成長率為 8.90%。

主要市場統計數據
基準年 2025 3.1233億美元
預計年份：2026年 3.4265億美元
預測年份 2032 5.6743億美元
複合年成長率 (%) 8.90%

本文概述了臨床需求、技術進步和採購重點如何相互交織，並重新定義了腦脊髓液引流導管在醫療保健服務中的重要性。

腦脊髓液引流導管在神經外科、重症監護和門診治療中扮演著至關重要的角色。器械材料、感染控制和操作指南的進步逐漸改變了臨床醫生對引流導管安全性和功能性的預期。臨床醫生越來越需要能夠精準定位、最大限度減少併發症並與監測系統整合的器械，而醫療系統則優先考慮供應的可靠性、成本效益以及對不斷變化的監管標準的符合性。

臨床進步、感染控制重點、門診護理的擴展以及供應鏈的韌性如何共同改變腦脊髓液引流導管的現況。

腦脊髓液引流導管的市場模式正經歷變革，這主要歸因於臨床、技術和醫療保健系統發展趨勢的相互作用。微創技術和影像引導置管技術縮短了手術時間，降低了併發症率，促使臨床醫生採用更先進的導管設計，以支援標靶治療和監測。同時，為預防感染所採取的措施也正在加速推廣表面技術和可降低器械相關感染的手術通訊協定，進而影響採購決策和臨床路徑。

評估 2025 年關稅趨勢將如何重塑腦脊髓液引流導管整個價值鏈的採購、製造地和商業策略。

2025年關稅政策變化所帶來的累積影響波及整個醫療設備生態系統的生產經濟性、籌資策略和供應鏈設計。關稅壓力推高了某些進口零件和成品的相對成本，迫使製造商重新評估其供應商所在地和採購條款。因此，一些製造商加快了近岸外包的步伐，實現了供應商多元化，並尋求簽訂長期合約以穩定投入價格並維持生產的連續性。

將產品設計、臨床應用、醫療保健環境、聚合物選擇和分銷管道與可操作的商業化和部署途徑聯繫起來的詳細細分見解。

基於產品組成、臨床應用、醫療環境、聚合物成分和銷售管道等因素評估醫療設備時，細分市場層面的趨勢揭示了影響因素和戰術性重點。按產品類型分類，市場研究涵蓋腰椎導管、脊髓硬膜外導管和腦室導管，每類產品都有其獨特的臨床操作要求、流量特性和設備整合的考量，這些都會影響臨床醫生的選擇和庫存管理。按應用分類，市場研究細分為腦脊髓液漏管理、水腦症、顱內壓監測和鞘內給藥，治療目標決定了從流量控制到藥物相容性和監測介面等設計重點。

區域分析揭示了美洲、歐洲、中東和非洲以及亞太地區的採用率、法規、採購慣例和供應鏈成熟度的差異。

區域趨勢影響著不同醫療生態系統中的技術應用、監管義務和採購慣例。在美洲，先進手術流程的採用正在穩步推進，重點在於與監測系統的整合。同時，支付方結構和醫院採購流程會影響價格談判和合約期限。相較之下，歐洲、中東和非洲地區的監管環境各異，基礎設施成熟度也存在差異，這就要求製造商根據當地的報銷機制和醫院能力調整臨床證據包和支持模式。

深入了解腦脊髓液引流導管領域主要企業的競爭定位、創新策略和商業化策略。

腦脊髓液引流導管領域的競爭格局取決於器材設計的創新、生產規模以及透過培訓和上市後監測為臨床醫生提供支援的能力。主要企業優先考慮差異化的價值提案，這些價值主張不僅限於導管本身，還包括操作培訓、滅菌包配置以及與監測系統的兼容性。卓越的生產能力和嚴格的品管仍然至關重要，因為器械的可靠性和感染控制性能是臨床醫生信心的關鍵決定因素。

為製造商和醫療保健系統提供切實可行的策略和營運建議，以擴大設備採用率、提高供應彈性並增強腦脊髓液引流治療的臨床效果。

產業領導企業應優先進行一系列合作舉措，以增強臨床可靠性、營運韌性和商業性吸引力。首先，投資於材料和表面創新，顯著降低感染風險並改善操作，同時確保透過完善的上市後監測和同行評審期刊發表的論文來累積臨床證據。其次，最佳化包裝、留置輔助設備和適用於門診環境的試劑盒，使產品開發與門診手術的需求保持一致，從而支持產品向不同臨床場所的過渡。

透明的調查方法，說明了主要訪談、二手證據的整合、細分一致性和品管，以深入了解實用設備。

本研究途徑結合了結構化的原始研究和全面的二手信息，以確保分析的嚴謹性和相關性。原始資訊包括對神經外科醫生、介入臨床醫生、採購經理和生產主管的訪談，從而獲得關於臨床工作流程、醫療設備性能重點和採購限制的第一手觀點。二手資訊涵蓋了同行評審的臨床文獻、監管指導文件、醫療設備附加檔和上市公司披露信息，並與原始反饋進行交叉比對，以檢驗趨勢並闡明臨床模式的背景。

本文概述了臨床、營運和供應鏈優先事項如何匯聚，並將決定腦脊髓液引流導管領域的未來成功。

總而言之，腦脊髓液引流導管正不斷發展，以滿足臨床需求、監管要求和不斷變化的醫療服務模式。材料科學的進步、對感染預防的重視以及向門診模式的轉變，正在影響導管的設計重點和商業化策略。供應鏈和貿易政策的趨勢使得採購的柔軟性和總成本透明度至關重要，而區域差異則要求採取因地制宜的市場進入策略，以反映當地的監管和基礎設施實際情況。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 腦脊髓液引流導管市場：依產品類型分類

  • 腰椎導管
  • 脊髓硬膜外導管
  • 心室導管

第9章 腦脊髓液引流導管市場：依材料分類

  • 聚乙烯
  • 聚氨酯
  • 矽酮

第10章 腦脊髓液引流導管市場：依應用領域分類

  • 腦脊髓液漏的處理
  • 水腦症
  • 顱內壓監測
  • 鞘內給藥

第11章 腦脊髓液引流導管市場：依最終用途分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 腦脊髓液引流導管市場：依通路分類

  • 直銷
  • 銷售代理
  • 線上零售

第13章 腦脊髓液引流導管市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 腦脊髓液引流導管市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 腦脊髓液引流導管市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國腦脊髓液引流導管市場

第17章：中國腦脊髓液引流導管市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical, LLC
  • ICU Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-035590447E22

The Cerebrospinal Fluid Drainage Catheter Market was valued at USD 312.33 million in 2025 and is projected to grow to USD 342.65 million in 2026, with a CAGR of 8.90%, reaching USD 567.43 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 312.33 million
Estimated Year [2026] USD 342.65 million
Forecast Year [2032] USD 567.43 million
CAGR (%) 8.90%

Foundational overview explaining how clinical needs, technological advances, and procurement priorities converge to redefine cerebrospinal fluid drainage catheter significance in care delivery

Cerebrospinal fluid drainage catheters sit at the intersection of neurosurgery, critical care, and ambulatory intervention. Advances in device materials, infection mitigation, and procedural guidance have progressively reshaped clinical expectations for drainage catheter safety and functionality. Clinicians increasingly demand devices that enable precise placement, minimize complications, and integrate with monitoring systems, while health systems prioritize supply reliability, cost efficiency, and compliance with evolving regulatory standards.

Against this backdrop, understanding the device landscape requires a clear grasp of clinical use cases, the engineering tradeoffs of polymer selection, and the impact of distribution dynamics on procurement. Innovations in catheter design have been driven by patient-centric goals such as reduced infection risk, improved flow control, and compatibility with imaging and monitoring platforms. At the same time, purchasers and clinicians are focused on device traceability, sterility assurances, and streamlined inventory management. Consequently, strategic stakeholders must balance clinical performance with operational considerations to make informed choices that support both patient outcomes and institutional resilience.

How clinical advancements, infection control priorities, outpatient care growth, and supply chain resilience are jointly transforming the cerebrospinal fluid drainage catheter landscape

The landscape for cerebrospinal fluid drainage catheters is undergoing transformative shifts shaped by converging clinical, technological, and health-system trends. Minimally invasive techniques and image-guided placement have reduced procedure times and complication rates, prompting clinicians to adopt refined catheter designs that support targeted therapies and monitoring. In parallel, the quest for infection prevention has accelerated adoption of surface technologies and procedural protocols that mitigate device-related infections, influencing purchasing decisions and clinical pathways.

Another significant shift is the decentralization of care, with ambulatory surgical centers and specialty clinics assuming a greater share of elective procedures. This trend requires devices that are easy to deploy, maintain consistent quality across diverse settings, and align with outpatient reimbursement models. Moreover, supply chain resilience has emerged as a strategic priority; manufacturers and health systems are investing in diversified sourcing and inventory visibility to minimize disruption. Finally, the integration of digital health elements, such as interoperable monitoring and data capture, is starting to influence device selection criteria, as stakeholders seek solutions that yield clinical insights and operational efficiencies.

Assessment of how 2025 tariff dynamics have reshaped procurement, manufacturing footprints, and commercial strategies across the cerebrospinal fluid drainage catheter value chain

The cumulative impact of tariff policy changes in 2025 has influenced production economics, procurement strategies, and supply chain design across the medical device ecosystem. Tariff pressures have raised the relative cost of certain imported components and finished devices, prompting manufacturers to reassess supplier footprints and procurement terms. As a result, some producers accelerated nearshoring initiatives, diversified vendor bases, and pursued longer-term contracts to stabilize input pricing and maintain manufacturing continuity.

Purchasing organizations responded by revisiting sourcing strategies, increasing demand for transparent total-cost-of-ownership analyses, and negotiating price-protection clauses. In some cases, distributors adjusted channel strategies to absorb short-term cost volatility while working with manufacturers to preserve clinical access and product availability. Regulatory and customs compliance burdens also increased administrative complexity, encouraging companies to invest in enhanced trade compliance capabilities and to explore alternative logistics models. Collectively, these adaptations have reinforced the importance of flexible manufacturing, robust supplier qualification processes, and proactive commercial measures to mitigate tariff-driven disruptions.

Detailed segmentation insights linking product designs, clinical applications, care settings, polymer choices, and distribution channels to practical commercialization and adoption pathways

Segment-level dynamics reveal nuanced drivers and tactical priorities when devices are evaluated by product configuration, clinical application, care setting, polymer composition, and sales channel. Based on Product Type, the market is studied across Lumbar Catheter, Spinal Epidural Catheter, and Ventricular Catheter, and each product class presents distinct clinical handling requirements, flow characteristics, and device integration considerations that influence clinician preference and inventory management. Based on Application, the market is studied across Cerebrospinal Fluid Leak Management, Hydrocephalus, Intracranial Pressure Monitoring, and Intrathecal Drug Delivery, and therapeutic intent guides design priorities from flow regulation to drug compatibility and monitoring interface.

Based on End Use, the market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics, and the distribution of procedures across these settings affects logistics, training needs, and purchasing cycles. Based on Material, the market is studied across Polyethylene, Polyurethane, and Silicone, and material selection determines flexibility, biocompatibility, and long-term durability, driving engineering trade-offs. Based on Distribution Channel, the market is studied across Direct Sales, Distributors, and Online Retail, and channel choice shapes commercialization strategies, customer support models, and pricing transparency. Taken together, these segmentation lenses enable stakeholders to prioritize development and commercialization choices that align with clinical workflow realities and procurement constraints.

Regional analysis highlighting how adoption, regulation, procurement practices, and supply chain maturity differ across the Americas, Europe Middle East & Africa, and Asia-Pacific regions

Regional dynamics shape technology adoption, regulatory obligations, and procurement practices across distinct healthcare ecosystems. Americas markets display strong adoption of advanced procedural workflows and place a premium on integration with monitoring systems, while payer structures and hospital procurement processes influence pricing negotiations and contract durations. In contrast, Europe, Middle East & Africa exhibits heterogenous regulatory landscapes and variable infrastructure maturity, prompting manufacturers to tailor clinical evidence packages and support models to local reimbursement and hospital capabilities.

Asia-Pacific demonstrates rapid procedural volume growth in many centers of excellence, with manufacturers focusing on scalable training programs and regional manufacturing partnerships to meet demand. Differences in supply chain maturity and local manufacturing capacity further influence lead times and inventory management practices across regions. Across all geographies, stakeholders increasingly evaluate product introduction through the lens of clinical outcomes, cost transparency, and supply resilience, which in turn guides regional go-to-market strategies and investment priorities.

Insights into competitive positioning, innovation strategies, and commercialization tactics that distinguish leading organizations in the cerebrospinal fluid drainage catheter domain

Competitive dynamics in the cerebrospinal fluid drainage catheter arena are defined by innovation in device design, manufacturing scale, and the ability to support clinicians with training and post-market surveillance. Leading firms prioritize differentiated value propositions that extend beyond the catheter itself to include procedural training, sterile kit configurations, and compatibility with monitoring ecosystems. Manufacturing excellence and stringent quality systems remain critical, as device reliability and infection control performance are primary determinants of clinician trust.

Partnerships with hospital systems, clinical research centers, and distribution networks enable manufacturers to accelerate adoption, while selective acquisitions and licensing agreements can fill technology gaps or expand product portfolios. Companies that demonstrate agility in regulatory submission processes and that invest in real-world evidence generation tend to secure stronger clinical adoption. At the same time, the capacity to offer flexible commercial models-such as consignment, bundled service offerings, or outcome-based contracting-differentiates those able to meet evolving procurement preferences and institutional budgetary pressures.

Actionable strategic and operational recommendations for manufacturers and health systems to enhance device adoption, supply resilience, and clinical outcomes in cerebrospinal fluid drainage therapies

Industry leaders should prioritize a set of coordinated actions to solidify clinical credibility, operational resilience, and commercial traction. First, invest in material and surface innovations that demonstrably reduce infection risk and improve handling, ensuring that clinical evidence is generated through robust post-market studies and peer-reviewed publications. Secondly, align product development with outpatient procedural needs by optimizing packaging, placement aids, and kits for ambulatory environments, thereby supporting the shift in care venues.

Third, enhance supply chain visibility by qualifying multiple suppliers for critical polymers and components, implementing inventory management solutions, and exploring regional manufacturing partnerships to reduce lead-time exposure. Fourth, expand clinician engagement through comprehensive training programs, simulation resources, and clinician champions to accelerate adoption and reduce device-related complications. Fifth, develop flexible commercial arrangements that accommodate hospital procurement cycles and support value-based purchasing models, while maintaining transparent pricing structures.

Finally, integrate digital enablement where appropriate, such as interoperable monitoring, traceability features, and analytics that support quality assurance and clinician decision-making. Taken together, these measures will strengthen product differentiation, support sustainable adoption, and protect commercial performance in a dynamic policy and procurement environment.

Transparent research methodology describing primary interviews, secondary evidence synthesis, segmentation alignment, and quality controls applied to generate actionable device insights

The research approach combined structured primary inquiry with comprehensive secondary synthesis to ensure analytical rigor and relevance. Primary inputs included interviews with neurosurgeons, interventional clinicians, procurement leaders, and manufacturing operations executives, which provided first-hand perspectives on clinical workflows, device performance priorities, and sourcing constraints. Secondary sources encompassed peer-reviewed clinical literature, regulatory guidance documents, device labeling, and public company disclosures, which were triangulated against primary feedback to validate trends and contextualize practice patterns.

Data integrity was reinforced through cross-validation across multiple respondent types and geographic markets to capture regional nuances. The analysis also applied a segmentation framework that aligned product classes, clinical applications, end-use settings, material choices, and distribution channels to highlight differential drivers and barriers. Quality control measures included review cycles with clinical advisors and supply chain specialists to ensure factual accuracy and to refine interpretive conclusions. The methodology emphasizes transparent provenance for insight generation and documents assumptions to support reproducibility and client validation.

Concluding synthesis emphasizing how clinical, operational, and supply chain priorities converge to determine future success in the cerebrospinal fluid drainage catheter sector

In summary, cerebrospinal fluid drainage catheters are evolving in response to clinical imperatives, regulatory expectations, and shifting care delivery models. Material science improvements, infection prevention focus, and the migration of procedures to outpatient settings are shaping design priorities and commercialization strategies. Supply chain and trade policy dynamics have elevated the importance of sourcing flexibility and total-cost transparency, while regional differences call for localized go-to-market approaches that reflect regulatory and infrastructure realities.

Strategic stakeholders who integrate clinical evidence generation, robust supply strategies, and clinician engagement programs will be better positioned to capture value and drive sustainable adoption. The path forward favors organizations that balance engineering innovation with operational excellence and that deliver measurable improvements in patient safety and clinician workflow. In this context, a focused, evidence-led approach to product development and commercialization will be essential for long-term success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cerebrospinal Fluid Drainage Catheter Market, by Product Type

  • 8.1. Lumbar Catheter
  • 8.2. Spinal Epidural Catheter
  • 8.3. Ventricular Catheter

9. Cerebrospinal Fluid Drainage Catheter Market, by Material

  • 9.1. Polyethylene
  • 9.2. Polyurethane
  • 9.3. Silicone

10. Cerebrospinal Fluid Drainage Catheter Market, by Application

  • 10.1. Cerebrospinal Fluid Leak Management
  • 10.2. Hydrocephalus
  • 10.3. Intracranial Pressure Monitoring
  • 10.4. Intrathecal Drug Delivery

11. Cerebrospinal Fluid Drainage Catheter Market, by End Use

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Cerebrospinal Fluid Drainage Catheter Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Retail

13. Cerebrospinal Fluid Drainage Catheter Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cerebrospinal Fluid Drainage Catheter Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cerebrospinal Fluid Drainage Catheter Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Cerebrospinal Fluid Drainage Catheter Market

17. China Cerebrospinal Fluid Drainage Catheter Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AngioDynamics, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Baxter International Inc.
  • 18.9. Becton, Dickinson and Company
  • 18.10. Boston Scientific Corporation
  • 18.11. Cook Medical, LLC
  • 18.12. ICU Medical, Inc.
  • 18.13. Integra LifeSciences Holdings Corporation
  • 18.14. Johnson & Johnson Services, Inc.
  • 18.15. Medtronic plc
  • 18.16. Merit Medical Systems, Inc.
  • 18.17. Stryker Corporation
  • 18.18. Teleflex Incorporated
  • 18.19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY LUMBAR CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY LUMBAR CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY LUMBAR CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SPINAL EPIDURAL CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SPINAL EPIDURAL CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SPINAL EPIDURAL CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY VENTRICULAR CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY VENTRICULAR CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY VENTRICULAR CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY CEREBROSPINAL FLUID LEAK MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY CEREBROSPINAL FLUID LEAK MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY CEREBROSPINAL FLUID LEAK MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY HYDROCEPHALUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY HYDROCEPHALUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY HYDROCEPHALUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY INTRATHECAL DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY INTRATHECAL DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY INTRATHECAL DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. GCC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GCC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. GCC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. GCC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. GCC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 116. GCC CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. G7 CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. G7 CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. G7 CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. G7 CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. G7 CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. NATO CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. NATO CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. NATO CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. NATO CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. NATO CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 140. NATO CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA CEREBROSPINAL FLUID DRAINAGE CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)